Skip to main content
. 2021 Sep 16;61(6):2360–2368. doi: 10.1093/rheumatology/keab684

Fig. 1.


Fig. 1

Patient disposition

aPatients who had contrast CT images evaluable before and after administration of tocilizumab for ≥48 weeks. TCZ: tocilizumab.